Biochemical assay for amyloid β deposits to distinguish Alzheimer's disease from other dementias

Batia Kaplan, Vahram Haroutunian, Alexei Koudinov, Yael Patael, Mordechai Pras, Gloria Gallo

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Biochemical markers for Alzheimer's disease (AD) are of great value for precise diagnosis and in studies of the pathogenetic processes of this disease. A new biochemical assay allowing to differentiate AD from other forms of dementia is described. The assay is based on the extraction of amyloid β (Aβ) from milligram amounts of brain tissue by using 20% acetonitrile in 0.1% trifluoroacetic acid and its detection by Western blotting. The presence of the 4 kDa Aβ was demonstrated in all cases of AD (n = 8) that were diagnosed by the independent histopathological examination of the postmortem tissues. No Aβ was found in tissue extracts from seven out of eight cases of other forms of dementia. In contrast to other biochemical techniques of Aβ detection in brain, the developed assay is simple; it does not require any special equipment and allows detection of Aβ using milligram amounts of brain tissue.

Original languageEnglish
Pages (from-to)147-159
Number of pages13
JournalClinica Chimica Acta
Volume280
Issue number1-2
DOIs
StatePublished - 1 Feb 1999

Keywords

  • Alzheimer's disease
  • Amyloid β
  • Biochemical assay
  • Western blotting

Fingerprint

Dive into the research topics of 'Biochemical assay for amyloid β deposits to distinguish Alzheimer's disease from other dementias'. Together they form a unique fingerprint.

Cite this